Published in Exp Clin Cardiol on January 01, 2012
Atrial fibrillation ablation and left appendage closure in heart failure patients. Curr Opin Cardiol (2015) 0.75
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med (1998) 23.22
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med (1992) 8.38
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med (2002) 8.37
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med (1995) 7.83
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation (2003) 6.83
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. J Am Coll Cardiol (2004) 5.05
Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med (2004) 4.99
Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med (2001) 4.81
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med (2000) 4.27
Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med (2008) 3.49
Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res (1999) 3.43
Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet (2000) 3.36
Altered myocardial force-frequency relation in human heart failure. Circulation (1992) 3.12
Medical management of advanced heart failure. JAMA (2002) 3.07
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med (1999) 2.99
Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA (2007) 2.93
Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol (2003) 2.73
Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation (2003) 2.61
Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol (2006) 2.56
Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses. J Am Coll Cardiol (2011) 2.42
Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol (2012) 2.40
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation (2001) 2.27
Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation (1998) 2.26
Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol (2005) 2.12
Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol (2003) 2.09
Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol (2004) 1.92
Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium. Circ Res (1999) 1.87
Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation (2000) 1.83
Complications of catheter ablation for atrial fibrillation: incidence and predictors. J Cardiovasc Electrophysiol (2008) 1.81
Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol (2008) 1.79
Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol (1997) 1.66
Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med (2008) 1.65
Rising rates of hospital admissions for atrial fibrillation. Epidemiology (2003) 1.62
Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation (1991) 1.61
Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation (2001) 1.51
Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm (2011) 1.48
Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol (2005) 1.45
Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med (2001) 1.38
Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol (2002) 1.34
Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation (2000) 1.32
Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. Circulation (2000) 1.19
Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias. J Interv Card Electrophysiol (1998) 1.10
The effect of atrial dilatation on the genesis of atrial arrhythmias. Cardiovasc Res (1989) 1.04
Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol (1998) 1.01
Effect of chronic right ventricular apical pacing on left ventricular function. Am J Cardiol (2005) 1.01
Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fibrillation versus sinus rhythm. Am J Cardiol (2001) 0.93
Atrial fibrillation in heart failure. N Engl J Med (1999) 0.92
Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study). Am J Cardiol (2007) 0.90
Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation. Circ Res (2000) 0.89
Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis. Am J Cardiol (1998) 0.88
Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm? Pacing Clin Electrophysiol (2000) 0.81
Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol (2008) 2.89
Thinning and flow of Tibetan crust constrained by seismic anisotropy. Science (2004) 2.05
Glycoprotein IIb/IIIa inhibitors with or without thienopyridine pretreatment improve outcomes after primary percutaneous coronary intervention in high-risk patients with ST elevation myocardial infarction--a meta-regression of randomized controlled trials. Catheter Cardiovasc Interv (2013) 1.40
Safety and efficacy of triple antithrombotic therapy after percutaneous coronary intervention in patients needing long-term anticoagulation. Ther Adv Cardiovasc Dis (2010) 1.39
Alcohol use and congestive heart failure: incidence, importance, and approaches to improved history taking. Heart Fail Rev (2007) 1.06
Sleep disordered breathing, daytime symptoms, and functional performance in stable heart failure. Sleep (2010) 1.00
Bisphosphonate use in women and the risk of atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol (2010) 0.93
Safety and efficacy of dronedarone in the treatment of atrial fibrillation/flutter. Clin Med Insights Cardiol (2011) 0.93
Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis. J Cardiovasc Pharmacol Ther (2011) 0.93
Utility of virtual crossmatch in sensitized patients awaiting heart transplantation. J Heart Lung Transplant (2009) 0.93
Suppression of ventricular tachycardia with dronedarone: a case report. J Cardiovasc Electrophysiol (2011) 0.93
Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal--medial thickness: a meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther (2010) 0.91
Nocturia, sleep and daytime function in stable heart failure. J Card Fail (2012) 0.88
Omega-3 fatty acid supplementation and cardiovascular disease events. JAMA (2013) 0.87
Effects of statins on progression of coronary artery disease as measured by intravascular ultrasound. J Clin Hypertens (Greenwich) (2011) 0.86
Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease. J Cardiovasc Pharmacol Ther (2010) 0.85
Psychological and social factors that correlate with dyspnea in heart failure. Psychosomatics (2006) 0.84
Outcomes of nonemergent percutaneous coronary intervention with and without on-site surgical backup: a meta-analysis. Am J Ther (2011) 0.83
A case of severe hypokalemic paralysis and hypertension. Licorice-induced hypokalemic paralysis. Am J Kidney Dis (2010) 0.82
Prevention of recurrent atrial fibrillation with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a systematic review and meta-analysis of randomized trials. J Cardiovasc Pharmacol Ther (2011) 0.79
Patients with obstructive sleep apnea display increased carotid intima media: a meta-analysis. Int J Vasc Med (2013) 0.79
Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era. Postgrad Med (2013) 0.79
Caffeine-related atrial fibrillation. Am J Ther (2010) 0.78
Safety and efficacy of transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction: a meta-analysis of randomized trials. Coron Artery Dis (2012) 0.78
Dabigatran: a new chapter in anticoagulation. Cardiovasc Hematol Agents Med Chem (2012) 0.77
Optimal atrioventricular delay in CRT patients can be approximated using surface electrocardiography and device electrograms. J Cardiovasc Electrophysiol (2010) 0.77
Prevalence of simultaneously measured interarm systolic blood pressure difference and its clinical and demographic predictors: a systemic review and meta-analysis. Blood Press Monit (2015) 0.76
Impact of Dobutamine in Patients With Septic Shock: A Meta-Regression Analysis. Am J Ther (2017) 0.76
Images of cecal volvulus from a strangulating fallopian tube: a case report. J Clin Med Res (2011) 0.75
Influence of age, gender, and race on depression in heart failure patients. J Am Coll Cardiol (2004) 0.75
A call to disarm: is malignancy higher in post-transplant patients? J Heart Lung Transplant (2006) 0.75
Thrombotic and fibrinolytic factors in acute coronary syndrome. South Med J (2010) 0.75
Radiofrequency ablation improving LV function in cardiomyopathy secondary to low burden of premature ventricular complexes. Anadolu Kardiyol Derg (2013) 0.75
Reply: Do We Need Individualized Therapeutic Strategies in High-Risk Patients Treated With Hypothermia? JACC Cardiovasc Interv (2017) 0.75
Atrial fibrillation following cardiac surgery: established and emerging strategies of prevention. Recent Pat Cardiovasc Drug Discov (2011) 0.75
Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story. Am J Ther (2016) 0.75
Addressing the controversy of rate-versus-rhythm control in atrial fibrillation. Postgrad Med (2013) 0.75
Venous thromboembolism in patients with heart failure: in-hospital and chronic use of anti-coagulants for prevention. Recent Pat Cardiovasc Drug Discov (2012) 0.75
On-X Valve: The Next Generation Aortic Valve. Cardiol Rev (2017) 0.75
Prasugrel: a novel antiplatelet therapy for acute coronary syndromes. Recent Pat Cardiovasc Drug Discov (2009) 0.75
Favorable effects of vasodilators on left ventricular remodeling in asymptomatic patients with chronic moderate-severe aortic regurgitation and normal ejection fraction: a meta-analysis of clinical trials. Clin Cardiol (2012) 0.75
Comparative Efficacy and Safety of Prasugrel, Ticagrelor, and Standard-Dose and High-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis. Am J Ther (2016) 0.75
Cardiotoxicity of Anticancer Therapies. Rev Cardiovasc Med (2015) 0.75
Seismic anisotropy: tracing plate dynamics in the mantle. Science (2002) 0.75
Ranolazine--treatment of ventricular tachycardia and symptomatic ventricular premature beats in ischemic cardiomyopathy. Pacing Clin Electrophysiol (2010) 0.75
Safety and efficacy of prolonged use of unfractionated heparin after percutaneous coronary intervention. Am J Ther (2010) 0.75
Supracardiac total anomalous pulmonary venous connection with a descending vertical vein. Pediatr Cardiol (2009) 0.75